Pterostilbene lowers the production of several lung cancer-promoting compounds, including MUC1, b-catenin, Sox2, NF-κB, and CD133.
Pterostilbene ຫຼຸດລົງການຜະລິດທາດປະສົມທີ່ສົ່ງເສີມມະເຮັງປອດ, ລວມທັງ MUC1, b-catenin, Sox2, NF-κB, ແລະ CD133.